GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
Neuroblastoma is an embryonic solid tumor of neural crest origin and accounts for 11% of all cancer-related deaths in children. Novel therapeutic strategies are therefore urgently required. MYCN oncogene amplification, which occurs in 20% of neuroblastomas, is a hallmark of high risk. Here, we aimed...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 13, 2014
|
| In: |
Cancer research
Year: 2014, Jahrgang: 74, Heft: 9, Pages: 2604-2616 |
| ISSN: | 1538-7445 |
| DOI: | 10.1158/0008-5472.CAN-13-1904 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/0008-5472.CAN-13-1904 Verlag, lizenzpflichtig, Volltext: https://cancerres.aacrjournals.org/content/74/9/2604 |
| Verfasserangaben: | Johannes Fabian, Marco Lodrini, Ina Oehme, Marie C. Schier, Theresa M. Thole, Thomas Hielscher, Annette Kopp-Schneider, Lennart Opitz, David Capper, Andreas von Deimling, Inga Wiegand, Till Milde, Ulrich Mahlknecht, Frank Westermann, Odilia Popanda, Frederik Roels, Barbara Hero, Frank Berthold, Matthias Fischer, Andreas E. Kulozik, Olaf Witt, and Hedwig E. Deubzer |
Search Result 1
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
2014
Buch/Monographie
Hochschulschrift